{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:30:22Z","timestamp":1793230222023,"version":"4.5.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      This multicenter prospective study sponsored by the\n                      <jats:italic>Grupo Espa\u00f1ol de Transplante Hematopoye\u0301tico y Terapia Celular<\/jats:italic>\n                      (GETH-TC) explores the use of frailty assessments in allo-HCT candidates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Frailty was measured using the HCT Frailty Scale at first consultation and HCT admission in 404 adults from 15 HCT programs in Spain. Based on the results, patients were classified into fit, pre-frail and frail categories. Allo-HCT outcomes were analyzed according to the results obtained from the HCT Frailty Scale. Data was collected prospectively and all patients signed informed consent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At first consultation, 102 (26.2%) patients were classified as fit, 248 (61.4%) as pre-frail, and 50 (12.4%) as frail. During the study, 62 (15.2%) patients participated in a pre-habilitation program. Among non-pre-habilitated patients (n=342), the proportion of fit patients decreased from 26.6% to 16.7%, while frail patients increased from 12.7% to 19.9%. In contrast, pre-habilitated patients (n=62) showed improvements, with fit patients increasing from 24.2% to 46.8%, and frail patients decreasing from 9.7% to 3.2%. Multivariate analysis confirmed lower OS (HR 2.52, P=0.002) and higher NRM (HR 2.69, P=0.013) in frail patients at HCT admission compared to fit ones, with a trend towards lower OS in pre-frail patients (HR 1.54, P=0.097).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the feasibility of incorporating the HCT Frailty Scale into clinical practice, confirms its negative impact of frailty on transplant outcomes, and suggests that frailty is dynamic and potentially reversible through pre-transplant interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1512154","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T02:45:28Z","timestamp":1736217928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care"],"prefix":"10.3389","volume":"15","author":[{"given":"Mar\u00eda Queralt","family":"Salas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Baile Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Acera G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"P\u00e9rez Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Quintela Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"S\u00e1nchez Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquina M.","family":"Salmer\u00f3n Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Illana \u00c1lvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Abdallahi-Lefdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cornago Navascues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fern\u00e1ndez-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leddy Patricia","family":"Vega Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Beorlegui-Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Esquirol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Izquierdo Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rodr\u00edguez Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mussetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Lavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Lopez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Filaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Cedillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyre","family":"Bento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.02.001","article-title":"Improving safety and outcomes after allogeneic hematopoietic cell transplantation: A single-center experience","volume":"28","author":"Salas","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/978-3-030-02278-5_68","article-title":"HSCT in elderly patients","volume-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","author":"Duarte","year":"2019"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for Autologous and allogeneic hematopoietic cell transplantation: guidelines from the American society for blood and marrow transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.03.002","article-title":"Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American society for transplantation and cellular therapy","volume":"26","author":"Kanate","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7559","article-title":"Eligibility criteria for patients undergoing allogeneic hematopoietic cell transplantation","volume":"18","author":"Kanate","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-746420","article-title":"Frailty and the management of hematologic Malignancies","volume":"131","author":"Abel","year":"2018","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/bmt.2017.192","article-title":"Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment","volume":"53","author":"Hegde","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.03.022","article-title":"Frailty consensus: a call to action","volume":"14","author":"Morley","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2019.09.012","article-title":"Use of geriatric assessment in hematopoietic cell transplant","volume":"11","author":"Jayani","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2018.05.013","article-title":"Fighting for the integration of geriatric principles into oncology","volume":"9","author":"Klepin","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2014.03.001","article-title":"Feasibility of geriatric assessment in community oncology clinics","volume":"5","author":"Williams","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.8170","article-title":"Time to stop saying geriatric assessment is too time consuming","volume":"35","author":"Hamaker","year":"2017","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.103655","article-title":"Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients","volume":"99","author":"Muffly","year":"2014","journal-title":"Haematologica"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0021-4","article-title":"Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis","volume":"53","author":"Deschler","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2014.04.004","article-title":"Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates","volume":"5","author":"Holmes","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0654-6","article-title":"Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic Malignancies","volume":"55","author":"Lin","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.01.028","article-title":"Limitation in patient-reported function is associated with inferior survival in older adults undergoing autologous hematopoietic cell transplantation","volume":"25","author":"Nawas","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0979-1","article-title":"Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation","volume":"56","author":"Salas","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01892-3","article-title":"Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults","volume":"58","author":"Salas","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02088-z","article-title":"HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation","volume":"58","author":"Salas","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1519\/00139143-200831010-00002","article-title":"Hand-grip dynamometry predicts future outcomes in aging adults","volume":"31","author":"Bohannon","year":"2008","journal-title":"J Geriatr Phys Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001719","article-title":"Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes","volume":"4","author":"Olin","year":"2020","journal-title":"Blood Adv"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: A report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. the 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12603-013-0437-5","article-title":"Cognitive frailty: rational and definition from an (I.A.N.A.\/I.A.G.G.) international consensus group","volume":"18","author":"Dartigues","year":"2014","journal-title":"J Nutr Health Aging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.05.015","article-title":"Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation","volume":"12","author":"Artz","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-3-219","article-title":"Frailty, inequality and resilience","volume":"19","author":"Hale","year":"2019","journal-title":"Clin Med (Lond)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S45300","article-title":"Frailty syndrome: an overview","volume":"9","author":"Chen","year":"2014","journal-title":"Clin Interv Aging"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.4.418","article-title":"Transitions between frailty states among community-living older persons","volume":"166","author":"Gill","year":"2006","journal-title":"Arch Intern Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000211949","article-title":"Frailty syndrome: a transitional state in a dynamic process","volume":"55","author":"Lang","year":"2009","journal-title":"Gerontology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000002428","article-title":"The role of outpatient physical medicine and rehabilitation in a multidisciplinary prehabilitation program for older adults before allogeneic hematopoietic stem cell transplant","volume":"103","author":"Cheng","year":"2024","journal-title":"Am J Phys Med Rehabil"},{"key":"B44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.physio.2021.08.001","article-title":"Feasibility and benefits of a structured prehabilitation programme prior to autologous stem cell transplantation (ASCT) in patients with myeloma; a prospective feasibility study","volume":"113","author":"Mawson","year":"2021","journal-title":"Physiotherapy"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.10.007","article-title":"Pretransplantation exercise and hematopoietic cell transplantation survival: A secondary analysis of blood and marrow transplant clinical trials network (BMT CTN 0902)","volume":"23","author":"Wingard","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-019-02149-1","article-title":"Quality of life is substantially worse for community-dwelling older people living with frailty: systematic review and meta-analysis","volume":"28","author":"Crocker","year":"2019","journal-title":"Qual Life Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2034159","article-title":"Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation","volume":"63","author":"Nagayama","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.02.016","article-title":"Evolution of body composition following autologous and allogeneic hematopoietic cell transplantation: incidence of sarcopenia and association with clinical outcomes","volume":"24","author":"DeFilipp","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04696-2","article-title":"Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice","volume":"27","author":"Preussler","year":"2019","journal-title":"Support Care Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.04.020","article-title":"The transplantation ecosystem: A new concept to improve access and outcomes for older allogeneic hematopoietic cell transplantation patients","volume":"29","author":"Wall","year":"2023","journal-title":"Transplant Cell Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1512154\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T02:45:32Z","timestamp":1736217932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1512154\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2024.1512154"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1512154","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1512154"}}